Friday, January 30, 2026 | 12:38 AM ISTहिंदी में पढें
Corona Remedies Ltd
Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results On Standalone And Consolidated Basis For The Third Quarter And Nine Months Ended On December 31 2025
03:49 PM, 27th Jan 2026
Corona Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2026 inter alia to consider and approve Board Meeting intimation for consideration and approval of Unaudited Financial Results on Standalone and Consolidated basis for the third quarter and nine months ended on December 31 2025